SPRB Spruce Biosciences, Inc.
Healthcare$53.15+0.00%OpenMarket Cap: $72.9M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$211.50
Target (Median)
$211.50
Target Range
$140.00 - $283.00
Upside from current price: 297.9%
Rating Distribution
1 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-10 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-12-03 | Leerink Partners | upgrade | Outperform | Market Perform |
| 2025-11-11 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-10-28 | JMP Securities | upgrade | Market Outperform | Market Perform |
| 2025-10-21 | Leerink Partners | maintain | Market Perform | Market Perform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.90 | $76.6M | 3 |
| Sun Dec 31 | $-11.49 | $24.2M | 2 |
| Mon Dec 31 | $-2.74 | $52.3M | 1 |
| Tue Dec 31 | $11.78 | $88.6M | 1 |